Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG oncology/gynecologic oncology group study

Martee L. Hensley, Danielle Enserro, Helen Hatcher, Petronella B. Ottevanger, Anders Krarup-Hansen, Jean Yves Blay, Cyril Fisher, Katherine M. Moxley, Shashikant B. Lele, Jayanthi S Lea, Krishnansu S. Tewari, Premal H. Thaker, Oliver Zivanovic, David M. O'Malley, Katina Robison, David S Miller